Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 8/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.55 |
| ▸ | PPARD | Q03181 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | NQO2 | P16083 | 5/20 | 0.43 |
| ▸ | MTNR1A | P48039 | 5/20 | 0.43 |
| ▸ | MTNR1B | P49286 | 5/20 | 0.43 |
| ▸ | HTR2A | P28223 | 3/20 | 0.40 |
| ▸ | HTR2C | P28335 | 3/20 | 0.40 |
| ▸ | HTR2B | P41595 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13424132 | 0.82 | MTNR1A (0.55) | CYP11B1CYP11B2PPARDNQO2MTNR1A | |
| SCHEMBL1470331 | 0.80 | MTNR1A (0.60) | NQO2MTNR1AMTNR1B | |
| SCHEMBL24496045 | 0.79 | HTR2C (0.50) | CYP11B1CYP11B2PPARDPPARANQO2 | |
| SCHEMBL5641289 | 0.78 | PPARD (0.62) | PPARDPPARAFFAR1 | |
| SCHEMBL30618514 | 0.78 | CYP1A2 (0.47) | CYP11B1CYP11B2PPARDMTNR1AMTNR1B | |
| SCHEMBL3348647 | 0.78 | CYP1A2 (0.47) | CYP11B1CYP11B2PPARDMTNR1AMTNR1B | |
| SCHEMBL14508397 | 0.77 | PPARD (0.40) | CYP11B1CYP11B2PPARDNQO2MTNR1A | |
| SCHEMBL7566057 | 0.77 | CYP11B1 (0.48) | CYP11B1CYP11B2NQO2MTNR1AMTNR1B | |
| SCHEMBL23934435 | 0.76 | HTR2C (0.48) | NQO2MTNR1AMTNR1BHTR2AHTR2C | |
| SCHEMBL8011041 | 0.76 | MTNR1A (0.46) | NQO2MTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | SYNGENTA PARTICIPATIONS AG (CH) | 2021-10-05 | — | — | US | disclosed |
| US-20190330148-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2019-10-31 | — | — | US | disclosed |
| WO-2018050477-A1 | PLANT GROWTH REGULATOR COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11136292-B2 | Plant growth regulator compounds | FGF1, MST1, CDC20 | CYP11B1 2334/4885CYP11B2 3052/4885PPARD 3554/4885 |
| US-20190330148-A1 | PLANT GROWTH REGULATOR COMPOUNDS | FGF1, MST1, CDC20 | CYP11B1 2334/4885CYP11B2 3052/4885PPARD 3554/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.